Press - Genomind

Genetic Testing for Mental Health Approved as New Ally for Military Personnel and Veterans

Veterans and active military personnel are now eligible to receive the Genecept Assay®, a genetic test for mental health that helps patients feel better.

Clinicians and Patients Gain Powerful Advanced Test for Mental Health as the Genecept Assay Builds on Existing Patient Success

Genomind has expanded its existing panel to 18 total genes based on the critical examination of hundreds of published studies showing that variations in these genes can inform treatment decisions in p

Genomind’s Cutting-Edge Pharmacogenetic Testing To Be Featured On Educational “Innovations” TV Series

“Innovations,” an award-winning television series seen on the Discovery Channel, will feature Genomind in a seven-minute segment that is set to premiere Monday, Dec. 14 at 7:30 a.m. EST and 7:30 a.m.

Genomind Appoints New Chief Medical Officer as Personalized Medicine Company Advances Work on Brain Health

Personalized Medicine for Mental Health Revolutionizes Care as Advocates Mark Mental Illness Awareness Week and World Mental Health Day

Genomind Secures Latest Round of Financing that Will Solidify Strategic Plan for Company’s Growth

Genomind is excited to appoint Rina Wolf to its Board of Directors

Genecept Assay Open Label Trial Results Published In The Primary Care Companion For CNS Disorders

Genomind Expands And Strengthens Leadership Team

New Evidence Shows Genetic Testing May Help Target Use of Antidepressants

Genomind Case Studies Published In Primary Care Companion For CNS Disorders

Genomind White Paper Describing The Clinical Utility Of Pharmacogenetic Testing In Psychiatry Published In Psychiatry Journal

Genomind To Exhibit At 2014 NEI Psychopharmacology Congress

Genomind To Attend The American Academy Of Child & Adolescent Psychiatry (AACAP) Annual Meeting

Genomind Welcomes New Executive Team Member Thomas Hess

Genomind Clinical Study Demonstrates effectiveness of the Genecept™ Assay

Genomind To Exhibit At The APA Annual Meeting And The Clinical TMS Society Meeting

Genomind Secures Series A Investment Led By Claritas Capital To Fund Growth Of Their Personalized Medicine Company

ValueOptions And Genomind Announce Innovative Study Of Pharmacogenomic Testing For Treating Psychotic Disorders

Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay

Genomind’s Genetic Testing At Princeton House Promotes Personalized Care

Genomind To Exhibit At The American Academy Of Anti-Aging (A4M) Congress

Genomind Announces New Patient Outcomes Data Supporting Use Of The Genecept Assay At NEI Global Psychopharmacology Congress

Dr. Jay Lombard Of Genomind Selected To Speak At Partnering For Cures (P4C) On “Mental Health: Research And Development At A Crossroads”

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Category: Press